Navigation Links
Catalan researchers identify a key component of cell division
Date:8/21/2012

This press release is available in Spanish and in French

- The Nek9 protein is required for chromosomes to separate into two identical groups.

- Nek9 exerts its action between two molecules of interest for the pharmaceutical industry as anti-tumoral agents, and for which inhibitors are already in advanced stages of clinical trials. Nek9 could be added to the list of candidates.

A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell division, a fundamental process for both the development of an organism and tissue maintenance. Headed by the researchers Joan Roig at IRB Barcelona and Isabelle Vernos at the CRG, the study describes that Nek9 is required for a cell to be able to divide the chromosomes into two identical groups in order to ensure efficient and accurate cell division. In fact, errors in the correct distribution of chromosomes cause many spontaneous miscarriages, some genetic defects such as trisomies, and are also related to the development of tumours.

"Through this study we demonstrate that a fourth family of proteins, namely NIMA and specifically Nek9, exert functions in cell division as important as those undertaken by the widely studied CDK (cdk1), Polo (Plk1) and Aurora (Aurora A and B) kinases", explains the scientist Joan Roig, specialist in the NIMA protein family and co-discoverer of Nek9.

The scientists study cell division and more specifically the first stages of mitosis or the process of the cell nucleus dividing in half. The distribution of the chromosomes requires the development of machinery that separates the two copies of the genetic material in such a way that the two resulting cells from the division inherit the same content. Nek9 participates in the preparation of the centrosomes, organelles involved in the organization of mitotic spindle development, a kind of "rugby ball" made up of microtubules or "molecular wiring", which, together with several "motors" pull and separate the chromosomes into two identical groups. The study reports that Nek9 modifies and controls NEDD1, the function of which was discovered in 2006 by Jens Luders, a researcher at IRB Barcelona, and a molecule involved in the formation of the new microtubules required to prepare the mitotic spindle. "Without Nek9 the spindle would not form properly and cell division would be hindered, the cells would die or cause aneuploidies, with unequal distribution of chromosomes, an event that is common in tumours", explains Isabelle Vernos, an expert in microtubules and cell division.

Interference with cell division is one of the main strategies used against cancer and the pharmaceutical industry is currently testing new drugs that inhibit Plk1, Aurora and Eg5. Nek9 falls between Plk1 and Eg5, the latter being a motor protein, whose function in mitosis Roig contributed to elucidate in a previous study. "We are doing double-edged work: we describe how proteins involved in the initial stages of cell division are related in time and space and in parallel we highlight the possible therapeutic tools, whether markers of disease or anti-mitotic agents, that can stop division and tumour growth", says Roig.

Conducted using eggs from the frog Xenopus laevis and human cells, the study is published today in Current Biology, one of the main journals devoted to basic biology.


'/>"/>
Contact: Sarah Sherwood
sarah.sherwood@irbbarcelona.org
34-934-034-636
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert

Related medicine news :

1. Spirituality correlates to better mental health regardless of religion, say MU researchers
2. IU researchers interview pro-anorexic bloggers for groundbreaking new study
3. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
4. Why are elderly duped? UI researchers explain why
5. Moffitt Cancer Center researchers validate molecular signature to predict radiation therapy benefit
6. By studying animal health, researchers find improved ways for developing, testing cancer therapies
7. Researchers aim to grow salivary glands using patients own cells
8. Moffitt Cancer Center researchers discover how cancer cells hijack a mechanism to grow
9. CNIO researchers discover a new therapy that prevents lung cancer growth in mice
10. BUSM researchers part of multi-center study on cardiac amyloidosis
11. BUSM/VA researchers uncover gender differences in the effects of long-term alcoholism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... ... July 19, 2017 , ... USHEALTH Group, Inc. ... Initiative in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... Its Treatments during Pregnancy , studies take a closer look at maternal depression, ... developing baby with one study showing newer medications may be safer choices. , ...
(Date:7/17/2017)... Connecticut (PRWEB) , ... July 17, 2017 , ... McGraw ... Enhance Patient Care and Train Next Generation of Healthcare Clinicians , NORWALK, Connecticut ... McGraw-Hill, is continuing its legacy of investing in community health by pledging up to ...
(Date:7/17/2017)... ... 2017 , ... Altec Products, Inc., a leader in enterprise document ... in Atlanta, Georgia. The four-day training session, which begins today and continues through ... more efficiently and effectively. , Covering topics such as Smart Form Toolkit, Security, ...
(Date:7/17/2017)... Pomona, California (PRWEB) , ... July 17, 2017 ... ... a “Great College to Work For” by the Chronicle of Higher Education for ... consecutive year. , WesternU, which has campuses in Pomona, California and Lebanon, Oregon, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, ... program to patients who suffer from painful intercourse and other painful pelvic ... vaginal atrophy due to menopause. ... VuVatech LLC ... created by Sarasota, Florida -based start-up company, VuVatech LLC, ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
(Date:7/10/2017)... RESEARCH TRIANGLE PARK, N.C. , July 10, 2017 ... of a $5m Convertible Note to support the development ... led by Tencent Holdings Limited, a leading Chinese Internet ... Center. This funding will advance multiple infectious disease product ... Founded by Dr. ...
Breaking Medicine Technology: